These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice. Ye D; Li FY; Lam KS; Li H; Jia W; Wang Y; Man K; Lo CM; Li X; Xu A Gut; 2012 Jul; 61(7):1058-67. PubMed ID: 22253482 [TBL] [Abstract][Full Text] [Related]
4. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice. Newberry EP; Xie Y; Kennedy SM; Luo J; Davidson NO Hepatology; 2006 Nov; 44(5):1191-205. PubMed ID: 17058218 [TBL] [Abstract][Full Text] [Related]
5. The mAb against adipocyte fatty acid-binding protein 2E4 attenuates the inflammation in the mouse model of high-fat diet-induced obesity via toll-like receptor 4 pathway. Miao X; Wang Y; Wang W; Lv X; Wang M; Yin H Mol Cell Endocrinol; 2015 Mar; 403():1-9. PubMed ID: 25596549 [TBL] [Abstract][Full Text] [Related]
6. Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis. Leroux A; Ferrere G; Godie V; Cailleux F; Renoud ML; Gaudin F; Naveau S; Prévot S; Makhzami S; Perlemuter G; Cassard-Doulcier AM J Hepatol; 2012 Jul; 57(1):141-9. PubMed ID: 22425624 [TBL] [Abstract][Full Text] [Related]
7. Neutralization of interleukin-17 attenuates high fat diet-induced non-alcoholic fatty liver disease in mice. Xu R; Tao A; Zhang S; Zhang M Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):726-33. PubMed ID: 23786840 [TBL] [Abstract][Full Text] [Related]
8. Celecoxib attenuates liver steatosis and inflammation in non-alcoholic steatohepatitis induced by high-fat diet in rats. Chen J; Liu D; Bai Q; Song J; Guan J; Gao J; Liu B; Ma X; Du Y Mol Med Rep; 2011; 4(5):811-6. PubMed ID: 21643627 [TBL] [Abstract][Full Text] [Related]
9. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice. Liu LF; Purushotham A; Wendel AA; Belury MA Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064 [TBL] [Abstract][Full Text] [Related]
10. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice. Zheng S; Hoos L; Cook J; Tetzloff G; Davis H; van Heek M; Hwa JJ Eur J Pharmacol; 2008 Apr; 584(1):118-24. PubMed ID: 18329014 [TBL] [Abstract][Full Text] [Related]
11. Kupffer cell activation is a causal factor for hepatic insulin resistance. Lanthier N; Molendi-Coste O; Horsmans Y; van Rooijen N; Cani PD; Leclercq IA Am J Physiol Gastrointest Liver Physiol; 2010 Jan; 298(1):G107-16. PubMed ID: 19875703 [TBL] [Abstract][Full Text] [Related]
12. Possible involvement and the mechanisms of excess trans-fatty acid consumption in severe NAFLD in mice. Obara N; Fukushima K; Ueno Y; Wakui Y; Kimura O; Tamai K; Kakazu E; Inoue J; Kondo Y; Ogawa N; Sato K; Tsuduki T; Ishida K; Shimosegawa T J Hepatol; 2010 Aug; 53(2):326-34. PubMed ID: 20462650 [TBL] [Abstract][Full Text] [Related]
13. FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation. Yao J; Zhou CS; Ma X; Fu BQ; Tao LS; Chen M; Xu YP World J Gastroenterol; 2014 Oct; 20(39):14430-41. PubMed ID: 25339829 [TBL] [Abstract][Full Text] [Related]
14. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice. Li L; Chen L; Hu L; Liu Y; Sun HY; Tang J; Hou YJ; Chang YX; Tu QQ; Feng GS; Shen F; Wu MC; Wang HY Hepatology; 2011 Nov; 54(5):1620-30. PubMed ID: 21809356 [TBL] [Abstract][Full Text] [Related]
15. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice. Min AK; Kim MK; Kim HS; Seo HY; Lee KU; Kim JG; Park KG; Lee IK Life Sci; 2012 Jan; 90(5-6):200-5. PubMed ID: 22154902 [TBL] [Abstract][Full Text] [Related]